Aug 3 (Reuters) - MiMedx Group Inc MDXG.O :
* MIMEDX ANNOUNCES SECOND QUARTER 2021 OPERATING AND
FINANCIAL
RESULTS
* Q2 SALES $68.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$58.8
MILLION
* ON TRACK TO DELIVER TOPLINE RESULTS FOR LATE-STAGE
MUSCULOSKELETAL PIPELINE IN LATE SUMMER
* QTRLY NET LOSS PER COMMON SHARE - DILUTED $0.03
* EXPECTS THAT ADJUSTED NET SALES FOR 2021 WILL BE
CONSISTENT WITH
THE PRIOR YEAR
* Q2 EARNINGS PER SHARE VIEW $-0.07 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX51KdcS
Further company coverage: MDXG.O
((Reuters.Briefs@thomsonreuters.com;))